P

Active Director Director DIN 10136079
DIN 10136079 First appointment Apr 2023 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value •••• Premium profile

About Pallavi

Data last updated:

Pallavi is a Director at Ailamord Healthcare Private Limited (since 2023). The company operates in Paper. Ailamord Healthcare Private Limited reported revenue of ₹3.3 Lakh (FY 2024).

DIN 10136079
Primary Designation Director
Industry Paper
First Appointment 27 Apr 2023
Oldest Company Age 3 yrs
Largest company Ailamord Healthcare Private Limited · ₹3.3 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ailamord Healthcare Private Limited U21002DL2023PTC413214
Director27 Apr 20232023₹3.3 Lakh (FY 2024)Active

Board colleagues of Pallavi

NameDINCompanyDesignation
Reeta Sharma10136080Ailamord Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ailamord Healthcare Private Limited
Premium access

Shareholding and investment profile for Pallavi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pallavi

Pallavi currently holds 1 directorship: Ailamord Healthcare Private Limited (Director, since 27 Apr 2023, revenue ₹3.3 Lakh (FY 2024)).

Pallavi was first appointed on 27 Apr 2023 as Director at Ailamord Healthcare Private Limited.

The current boards of Pallavi's companies include Reeta Sharma (Ailamord Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available